Related Experiment Video
Updated: Jul 6, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Comparative daily profiles with different preparations of lamotrigine: a pilot investigation
Kirsten Annette Nielsen1, Marit Dahl, Erling Tømmerup
1Danish Epilepsy Centre, 1 Kolonivej, DK-4293 Dianalund, Denmark. kirsns@vestamt.dk
Abstract:
Comparative pharmacokinetic data obtained with different preparations of lamotrigine (LTG) are reported for the first time. Nine outpatients reporting problems attributed to shifts in the preparation of LTG used were admitted to hospital. Patients were treated with proprietary LTG for at least 2 weeks prior to admission. Daily profiles (DPs) spanning 24 hours were obtained by blood sampling at 3- or 4-hour intervals on Day 3 after admission. A second DP was obtained under similar conditions after generic LTG therapy for at least 7 days. LTG concentrations were determined by HPLC, and DPs were generated to compare pharmacokinetic parameters. In five of nine patients, parameters deviated beyond +/-10%. Even with the narrower bioequivalence requirements for mandatory substitution in Denmark, there are some patients who experienced serious clinical consequences (relapse in a seizure-free patient, status epilepticus, epidural hematoma due to ataxia with falls) in association with a change in preparation, and significant corresponding alterations in plasma levels could be demonstrated by comparative pharmacokinetic testing.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Drug Dissolution: Requirements and Profile Comparison
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Dosage Regimens: Partial Pharmacokinetic Parameters
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies